8-KEarnings & ResultsExhibits & Filings

BIOGEN INC. 8-K Report, Financial Results (Apr 21, 2016)

Filed April 21, 2016For Securities:BIIB

Summary

Biogen Inc. (BIIB) announced its first-quarter 2016 financial results on April 21, 2016, via a press release furnished as part of this 8-K filing. This report primarily serves to disclose the company's operational and financial performance for the period ending March 31, 2016. Investors should refer to the press release, incorporated by reference, for specific details regarding revenue, earnings, and other key financial metrics. While the filing itself is brief and primarily ceremonial in nature, it formally communicates that Biogen has released its Q1 2016 earnings. The information contained within the referenced press release will be crucial for understanding the company's performance, including any updates on key drugs, pipeline developments, and forward-looking guidance. It's important for investors to note that this information is being furnished and not formally "filed," meaning it does not carry the same legal implications under Section 18 of the Exchange Act.

Key Highlights

  • 1Biogen Inc. reported its first-quarter 2016 financial results on April 21, 2016.
  • 2The results were disclosed via a press release, furnished as an exhibit to the 8-K.
  • 3The filing pertains to the operational and financial condition for the quarter ended March 31, 2016.
  • 4Investors should consult the press release (Exhibit 99.1) for detailed financial performance data.
  • 5The information is furnished under Item 2.02 and is not deemed 'filed' under Section 18 of the Exchange Act.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and provide access to Biogen Inc.'s first-quarter 2016 financial results, which were released through a press release.

The detailed financial results for the first quarter ended March 31, 2016, are contained within the press release that is furnished as Exhibit 99.1 to this 8-K filing and incorporated herein by reference.

This specific 8-K filing, based on the provided text, primarily concerns the announcement of financial results. Any significant business developments or strategic changes would likely be detailed within the accompanying press release or subsequent filings.

When information is 'furnished' under Item 2.02, it means it's being provided to the SEC for informational purposes but is not subject to the same liability provisions under Section 18 of the Securities Exchange Act of 1934 as formally 'filed' documents. It also means it won't automatically be incorporated into other SEC filings unless specifically stated.